Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 3
169
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Mechanistic exploration of the activities of poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid against hepatocellular carcinoma at cellular and molecular levels

, , , , , , , , & ORCID Icon show all
Pages 836-848 | Received 15 Nov 2019, Accepted 17 Feb 2020, Published online: 06 Mar 2020

References

  • Adamson, C.S., et al., 2009. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457). Journal of virology, 83 (10), 4884–4894.
  • Anadol, E., et al., 2012. The changes of inducible nitric oxide synthase, endothelial nitric oxide synthase and cyclooxygenase-2 mRNA expressions in intrauterine tissues of pregnant rats. Ankara üniversitesi veteriner fakültesi dergisi, 59, 295–301.
  • Armstrong, B. and Doll, R., 1975. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. International journal of cancer, 15 (4), 617–631.
  • Bruix, J. and Sherman, M., 2011. Management of hepatocellular carcinoma: an update. Hepatology, 53 (3), 1020–1022.
  • Brüne, B., et al., 1998. Nitric oxide and its role in apoptosis. European journal of pharmacology, 351 (3), 261–272.
  • Chandra, D., et al., 2002. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. Journal of biological chemistry, 277 (52), 50842–50854.
  • Chen, Y., et al., 2016. Plasma metabolomic analysis of human hepatocellular carcinoma: diagnostic and therapeutic study. Oncotarget, 7, 47332–47342.
  • Clemens, M.G., 1999. Nitric oxide in liver injury. Hepatology, 30 (1), 1–5.
  • Cragg, G.M., et al., 1997. Natural products in drug discovery and development. Journal of natural products, 60 (1), 52–60.
  • Davaran, S., et al., 2006. Adriamycin release from poly (lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization. International journal of nanomedicine, 1 (4), 535–539.
  • Delage, B., et al., 2010. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. International journal of cancer, 126, 2762–2772.
  • Dolkart, O., et al., 2014. Temporal determination of lung NO system and COX-2 upregulation following ischemia–reperfusion injury. Experimental lung research, 40 (1), 22–29.
  • Drag-Zalesinska, M., et al., 2009. Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells. Bioorganic & medicinal chemistry letters, 19, 4814–4817.
  • El-Say, K.M., 2016. Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper–Lin small composite design. Drug design. development and therapy, 10, 825.
  • Fages, A., et al., 2015. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC medicine, 13 (1), 242.
  • Fujioka, T., et al., 1994. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. Journal of natural products, 57 (2), 243–247.
  • Fulda, S., 2008. Betulinic acid for cancer treatment and prevention. International journal of molecular sciences, 9 (6), 1096–1107.
  • Fulda, S., et al., 1999. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells. International journal of cancer, 82 (3), 435–441.
  • Gao, H., et al., 2009. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer science, 100 (4), 782–785.
  • Huang, Q., et al., 2013. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer research, 73 (16), 4992–5002.
  • Huber, H.J., et al., 2011. Mathematical modelling of the mitochondrial apoptosis pathway. Biochimica et biophysica acta (BBA) - molecular cell research, 1813 (4), 608–615.
  • Jafari Anarkooli, I., et al., 2008. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Experimental diabetes research, 638467, 1–6.
  • Jäger, S., et al., 2008. A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules, 13 (12), 3224–3235.
  • Katsuhiko, Y. and Chisato, H., 1980. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease. Clinica chimica acta, 101 (2–3), 235–240.
  • Kondo, M., et al., 2017. Treatment of advanced hepatocellular carcinoma after failure of sorafenib treatment: subsequent or additional treatment interventions contribute to prolonged survival postprogression. Gastroenterology research and practice, 2017, 1–10.
  • Kumar, A., et al., 2015. Silibinin inhibits the hepatocellular carcinoma in NDEA-induced rodent carcinogenesis model: an evaluation through biochemical and bio-structural parameters. Journal of cancer science and therapy, 7, 1948–5956.
  • Kumar, P., et al., 2018. Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations. International journal of nanomedicine, 13, 975–990.
  • Liu, Y., et al., 2014. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis. International journal of cancer, 135 (3), 658–668.
  • Longley, D.B., et al., 2003. 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews cancer, 3 (5), 330–338.
  • Maurya, V., et al., 2019. Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis. Chemico-biological interactions, 308, 120–129.
  • Mayaux, J.F., et al., 1994. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proceedings of the national academy of sciences, 91 (9), 3564–3568.
  • Miranda, K.M., et al., 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide, 5 (1), 62–71.
  • Motawi, T.K., et al., 2008. Gastroprotective effect of leptin in indomethacin-induced gastric injury. Journal of biomedical science, 15 (3), 405–412.
  • Newman, D.J., et al., 2003. Natural products as sources of new drugs over the period 1981 − 2002. Journal of natural products, 66 (7), 1022–1037.
  • Puig-Castellví, F., et al., 2016. 1 H NMR metabolomic study of auxotrophic starvation in yeast using multivariate curve resolution-alternating least squares for pathway analysis. Scientific reports, 6 (1), 30982.
  • Qin, S., et al., 2013. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. Journal of clinical oncology, 31 (28), 3501–3508.
  • Quan-Jun, Y., et al., 2015. NMR-based metabolomics reveals distinct pathways mediated by curcumin in cachexia mice bearing CT26 tumor. RSC advances, 5 (16), 11766–11775.
  • Rahman, M. and Hasan, M.R., 2015. Cancer metabolism and drug resistance. Metabolites, 5 (4), 571–600.
  • Rang, H. P., et al., 2014. Rang & Dale’s pharmacology E-book. Elsevier Health Sciences.
  • Raouf, A.A., et al., 2016. Plasma free amino acid profile changes in hepatocellular carcinoma patients. Menoufia medical journal, 29, 895.
  • Roy, P., et al., 2010. Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations. International journal of nanomedicine, 5, 1113–1121.
  • Sahdev, A.K., et al., 2017. Ameliorative effects of pyrazinoic acid against oxidative and metabolic stress manifested in rats with dimethylhydrazine induced colonic carcinoma. Cancer biology & therapy, 18, 304–313.
  • Selzer, E., et al., 2000. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. Journal of investigative dermatology, 114 (5), 935–940.
  • Singh, A.K., et al., 2018a. Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals. Scientific reports, 8 (1), 5932.
  • Singh, A.K., et al., 2018b. Isolated mangiferin and naringenin exert antidiabetic effect via PPARγ/GLUT4 dual agonistic action with strong metabolic regulation. Chemico-biological interactions, 280, 33–44.
  • Snyder, C.M., et al., 2009. Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members. PLoS one, 4 (9), e7059.
  • Surveillance Research Program, National Cancer Institute Fast stats: an interactive tool for access to SEER cancer statistics. 2011 Nov 10. Available from: http://seer.cancer.gov/faststats
  • Swameye, I., et al., 2003. Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling. Proceedings of the national academy of sciences, 100 (3), 1028–1033.
  • Torre, L.A., et al., 2015. Global cancer statistics, 2012. CA: A cancer journal for clinicians, 65, 87–108.
  • Ulrich, E.L., et al., 2008. BioMagResBank. Nucleic acids research, 36, D402–D408.
  • Vander Heiden, M.G., 2011. Targeting cancer metabolism: a therapeutic window opens. Nature reviews drug discovery, 10 (9), 671–684.
  • Wang, H., et al., 2013. 1H NMR-based metabolic profiling of human rectal cancer tissue. Molecular cancer, 12 (1), 121.
  • Wick, W., et al., 1999. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. Journal of pharmacology and experimental therapeutics, 289 (3), 1306–1312.
  • Wilhelm, S., et al., 2006. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nature reviews drug discovery, 5 (10), 835–844.
  • Wishart, D.S., et al., 2007. HMDB: the human metabolome database. Nucleic acids research, 35, D521–D526.
  • Xia, J., et al., 2009. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic acids research, 37, W652–W660.
  • Xia, J., et al., 2015. MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic acids research, 43 (W1), W251–W257.
  • Xie, X., et al., 2011. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. Journal of agricultural and food chemistry, 59 (17), 9280–9289.
  • Xu, H., et al., 2012. Study on absorption kinetics of betulic acid in rat’s intestines. China journal of chinese materia medica, 37, 377–380.
  • Xu, W., et al., 2016. Activation of Bcl-2-caspase-9 apoptosis pathway in the testis of asthmatic mice. PLoS one, 11 (3), e0149353.
  • Zuco, V., et al., 2002. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer letters, 175 (1), 17–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.